Rock Springs Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-119,500
Closed -$58.2M 114
2024
Q2
$58.2M Sell
119,500
-59,750
-33% -$30M 1.75% 16
2024
Q1
$96.8M Hold
179,250
2.46% 8
2023
Q4
$99.5M Sell
179,250
-15,250
-8% -$7.16M 2.45% 12
2023
Q3
$85M Hold
194,500
2.28% 12
2023
Q2
$97.7M Sell
194,500
-13,000
-6% -$6.23M 2.32% 13
2023
Q1
$104M Hold
207,500
2.48% 11
2022
Q4
$84.7M Sell
207,500
-16,815
-7% -$6.53M 2.04% 12
2022
Q3
$73.1M Buy
224,315
+565
+0.3% +$208K 1.89% 13
2022
Q2
$78.5M Buy
223,750
+5,000
+2% +$2.04M 2.28% 10
2022
Q1
$120M Buy
218,750
+38,750
+22% +$20.4M 3.01% 5
2021
Q4
$119M Hold
180,000
2.74% 7
2021
Q3
$112M Hold
180,000
2.35% 8
2021
Q2
$114M Hold
180,000
2.25% 6
2021
Q1
$88.1M Buy
180,000
+55,000
+44% +$27.6M 1.92% 13
2020
Q4
$62.5M Hold
125,000
1.32% 23
2020
Q3
$49.1M Hold
125,000
1.25% 25
2020
Q2
$41.3M Hold
125,000
1.13% 30
2020
Q1
$30.3M Buy
125,000
+4,800
+4% +$1.25M 1.25% 30
2019
Q4
$31.4M Hold
120,200
0.99% 34
2019
Q3
$32.7M Hold
120,200
1.3% 25
2019
Q2
$33.1M Hold
120,200
1.2% 24
2019
Q1
$26.9M Buy
120,200
+9,700
+9% +$2M 1.04% 30
2018
Q4
$20.6M Buy
110,500
+27,000
+32% +$5.54M 0.97% 32
2018
Q3
$20.8M Buy
83,500
+11,500
+16% +$2.79M 0.75% 43
2018
Q2
$15.7M Buy
72,000
+9,000
+14% +$1.85M 0.6% 62
2018
Q1
$12.1M Buy
+63,000
New +$11.6M 0.51% 69
2016
Q1
Sell
-127,500
Closed -$9.3M 130
2015
Q4
$9.3M Buy
127,500
+15,000
+13% +$1.07M 0.7% 49
2015
Q3
$8.35M Buy
112,500
+1,500
+1% +$107K 0.68% 52
2015
Q2
$7.12M Buy
+111,000
New +$7.68M 0.52% 72

Other funds holding IDXX

Rock Springs Capital Management's IDXX Position: Q3 2024 in Review

Rock Springs Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 119,500 shares — an estimated $58.2M sold.

Rock Springs Capital Management first reported a position in IDXX in Q2 2015 and held it in 29 quarters. The position peaked at $120M in Q1 2022. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Rock Springs Capital Management reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 119,500 Idexx Laboratories shares in Q3 2024, an estimated $58.2M.
  • Rock Springs Capital Management first reported a position in Idexx Laboratories in Q2 2015 and held it in 29 quarters.
  • Rock Springs Capital Management's Idexx Laboratories position peaked at $120M in Q1 2022.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Rock Springs Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.